Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
25%
Ph phase_1
3
38%
Ph not_applicable
1
13%
Ph phase_4
1
13%

Phase Distribution

3

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
3(42.9%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(7)
Completed(1)

Detailed Status

Not yet recruiting3
Enrolling by invitation3
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (42.9%)
Phase 22 (28.6%)
Phase 41 (14.3%)
N/A1 (14.3%)

Trials by Status

completed113%
not_yet_recruiting338%
enrolling_by_invitation338%
recruiting113%

Recent Activity

1 active trials
Showing 5 of 8
not_yet_recruitingphase_4

Microbiological Characteristics of Biofilm on Double J Ureteral Stents After Lithotripsy.

NCT07301294
recruitingphase_2

Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

NCT05383742
enrolling_by_invitationphase_1

Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection

NCT07228702
not_yet_recruitingnot_applicable

6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province

NCT07198685
completed

Compare Linezolid-Induced Thrombocytopenia in Patients With Normal Renal Function Versus Impaired Renal Function

NCT06761131
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07301294Phase 4

Microbiological Characteristics of Biofilm on Double J Ureteral Stents After Lithotripsy.

Not Yet Recruiting
NCT05383742Phase 2

Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

Recruiting
NCT07228702Phase 1

Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection

Enrolling By Invitation
NCT07198685Not Applicable

6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province

Not Yet Recruiting
NCT06761131

Compare Linezolid-Induced Thrombocytopenia in Patients With Normal Renal Function Versus Impaired Renal Function

Completed
NCT06921213Phase 2

Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis

Not Yet Recruiting
NCT06811025Phase 1

Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis

Enrolling By Invitation
NCT06811012Phase 1

Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis

Enrolling By Invitation

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8